HIF1A and glioblastoma: It is therefore reasonable to infer that the EGCG-mediated suppression of HIF-1α contributes to the downstream inhibition of these adipogenic effectors 29, further reinforcing the compound's potential to disrupt hypoxia-induced metabolic adaptation in GBM.